Linike Medical Group (LNMG) Stock Statistics & Valuation Metrics
Total Valuation
Linike Medical Group has a market cap or net worth of $5.01M. The enterprise value is $23.32T.
- Market Cap
- $5.01M
- Enterprise Value
- $23.32T
Share Statistics
Linike Medical Group has 668,948,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 668,948,060
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Linike Medical Group’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.57%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 5.57%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.19
- Inventory Turnover
- 0.01
Valuation Ratios
The current PE Ratio of Linike Medical Group is 5.35. Linike Medical Group’s PEG ratio is -0.08.
- PE Ratio
- 5.35
- PS Ratio
- 0.53
- PB Ratio
- 0.13
- Price to FCF
- -7.78
- Price to Operating Cash Flow
- -11.04
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Linike Medical Group had revenue of 10.68M and earned 3.09M in profits. Earnings per share was 0.00.
- Revenue
- 10.68M
- Gross Profit
- 10.54M
- Operating Income
- 3.09M
- Pretax Income
- 3.09M
- Net Income
- 3.09M
- EBITDA
- 3.22M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -453.83K and capital expenditures -190,513, giving a free cash flow of -644.34K billion.
- Operating Cash Flow
- -453.83K
- Free Cash Flow
- -644.34K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Linike Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.86%
- Earnings Yield
- 23.14%
Stock Price Statistics
- Beta
- -1.57
- 52-Week Price Change
- -16.67%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 32.95
- Average Volume (3m)
- 16.00K
Financial Position
Linike Medical Group as a current ratio of 3.99, with Debt / Equity ratio of 45.81%
- Current Ratio
- 3.99
- Quick Ratio
- 2.74
- Debt to Market Cap
- 1.17
- Net Debt to EBITDA
- 5.25
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Linike Medical Group has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Linike Medical Group EV to EBITDA ratio is 15.52, with an EV/FCF ratio of -32.44.
- EV to Sales
- 2.21
- EV to EBITDA
- 15.52
- EV to Free Cash Flow
- -32.44
- EV to Operating Cash Flow
- -46.06
Balance Sheet
Linike Medical Group has $109.33K in cash and marketable securities with $16.00M in debt, giving a net cash position of -$15.89M billion.
- Cash & Marketable Securities
- $109.33K
- Total Debt
- $16.00M
- Net Cash
- -$15.89M
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- $0.06
Margins
Gross margin is 56.66%, with operating margin of 12.24%, and net profit margin of 12.24%.
- Gross Margin
- 56.66%
- Operating Margin
- 12.24%
- Pretax Margin
- 12.24%
- Net Profit Margin
- 12.24%
- EBITDA Margin
- 14.21%
- EBIT Margin
- 12.24%
Analyst Forecast
The average price target for Linike Medical Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
